8-KLeadership ChangesCorporate ChangesExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K Report, Executive Changes (Mar 9, 2007)

Filed March 9, 2007For Securities:BMYCELG-RIBMYMP

Summary

This 8-K filing from Bristol-Myers Squibb (BMY) on March 9, 2007, primarily reports on changes to the company's Board of Directors and its bylaws. The key event is the election of Michael Grobstein to the Board of Directors, effective March 6, 2007. His appointment also included a position on the Audit Committee, and the Board size was expanded to eleven members to accommodate this addition. The filing also details an amendment to the company's bylaws, made on March 7, 2007. This amendment removed the reference to an Executive Committee of the Board and specifically established the Compensation and Management Development Committee and the Committee on Directors and Corporate Governance. These changes indicate adjustments in the company's governance structure.

Key Highlights

  • 1Michael Grobstein elected to the Board of Directors, effective March 6, 2007.
  • 2Michael Grobstein appointed to the Audit Committee of the Board of Directors.
  • 3The size of the Board of Directors was increased to eleven members.
  • 4Bylaws amended on March 7, 2007, to remove reference to an Executive Committee.
  • 5Bylaws amended to specifically provide for the Compensation and Management Development Committee and the Committee on Directors and Corporate Governance.
  • 6The changes reflect adjustments to the company's corporate governance framework.

Frequently Asked Questions

The main purpose of this 8-K filing is to report significant corporate events, specifically the election of a new director to the Board and amendments to the company's bylaws.

Michael Grobstein was elected to the Board of Directors of Bristol-Myers Squibb and appointed to its Audit Committee, effective March 6, 2007. The filing does not provide specific details on his background or the exact reasons for his appointment beyond his role on the Audit Committee.

The company's bylaws were amended to eliminate the Executive Committee of the Board and to formally establish the Compensation and Management Development Committee and the Committee on Directors and Corporate Governance. This clarifies the structure and responsibilities of key board committees.

Michael Grobstein was elected to the Board and will stand for election by stockholders at the Annual Meeting of Stockholders in May 2007, indicating a process for formal stockholder approval of his directorship.